Swiss biotech, Evolva, has launched a natural sugar blocker used in food and beverages and reducing sugar applied in food processing.
Studies show that L-arabinose as sugar blocker can support healthy blood sugar levels and weight management.
It also has potential application as a prebiotic. As reducing sugar, L-arabinose is also frequently applied in the production of savoury flavours such as chicken and beef.
Made by fermentation, Evolva’s L-arabinose is fully renewable and sustainable, it has a high-purity level and no hydrochloric acid is used in the manufacturing process. It is FEMA GRAS approved for use in food and beverages.
According to Evola, L-Arabinose taste profile is well-suited for use in products such as yogurt, chocolate, soft drinks, ice cream, cereal, power bars and confectionary.
“As people around the world continue to strive to live a healthier lifestyle, we are committed to helping our customers create healthier, more sustainable solutions,” said Oliver Walker, CEO of Evolva.
“With this launch we are confirming our ability to deliver innovations that support human health and wellbeing.”
With a wide range of applications, L-arabinose has a current market value of CHF 250 million, which is expected to grow by at least 5% per annum.
Evolva is having commercial discussions with major customers, which include first supply volumes for 2021.